The KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital recently announced an innovative ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

The European Commission (EC) has approved Blincyto (blinatumomab) monotherapy as part of consolidation therapy for the treatment of adults with newly-diagnosed Philadelphia chromosome-negative ...

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

"It’s an honor and privilege for me to wear Alexa’s shoes," says Painter. Alexa Wood, 13, was diagnosed with leukemia hours ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Hammer Down Cancer game featured player-worn jerseys auctioned off for cancer research, and coaches' shoes will be auctioned ...

Braden Smith had a big night statistically Friday against Michigan. But it pales in comparison to the dollar figure his ...

Susannah and Elizabeth Castle are typical three-and-a-half-year-old girls: playful, energetic and silly. They’ve come a long ...